The role of upregulated miRNAs and the identification of novel mRNA targets in prostatospheres

Genomics

Volumn 99, Issue 2, 2012, Pages 108-117

  Cabarcas, Stephanie M ^a   Thomas, Suneetha ^b,d   Zhang, Xiaohu ^b   Cherry, James M ^c   Sebastian, Thomas ^c   Yerramilli, Subu ^c   Lader, Eric ^c   Farrar, William L ^a   Hurt, Elaine M ^a  

^a NATIONAL CANCER INSTITUTE   (United States)

^b SAIC FREDERICK INC   (United States)

^c Research and Development   (United States)

^d MEDIMMUNE   (United States)

Author keywords

Cancer stem cells; MicroRNA; Prostate cancer; Prostatospheres; Tumor initiating cell

Indexed keywords

MESSENGER RNA; MICRORNA;

ARTICLE; CANCER CELL; CELL DIFFERENTIATION; CELL RENEWAL; CONTROLLED STUDY; DOWN REGULATION; GENE EXPRESSION PROFILING; HUMAN; HUMAN CELL; MALE; PRIORITY JOURNAL; PROSTATE CANCER; PROSTATOSPHERE; TUMOR INITIATING CELL; UPREGULATION;

CELL PROLIFERATION; GENE EXPRESSION PROFILING; GENE EXPRESSION REGULATION, NEOPLASTIC; HUMANS; MALE; MICRORNAS; NEOPLASM RECURRENCE, LOCAL; NEOPLASTIC STEM CELLS; OLIGONUCLEOTIDE ARRAY SEQUENCE ANALYSIS; PROSTATIC NEOPLASMS; REAL-TIME POLYMERASE CHAIN REACTION; RNA, MESSENGER; SPHEROIDS, CELLULAR; TUMOR CELLS, CULTURED; UP-REGULATION;

EID: 84862802787     PISSN: 08887543     EISSN: 10898646     Source Type: Journal    
DOI: 10.1016/j.ygeno.2011.11.007     Document Type: Article

References (53)

1. Jemal A., Siegel R., Xu J., Ward E. Cancer statistics. CA Cancer J. Clin. 2010, 60(5):277-300. (Sep-Oct) [Electronic publication ahead of print].
2. Al-Hajj M., Wicha M.S., Benito-Hernandez A., Morrison S.J., Clarke M.F. Prospective identification of tumorigenic breast cancer cells. Proc. Natl. Acad. Sci. U. S. A. 2003, 100:3983-3988.
3. Ricci-Vitiani L., Lombardi D.G., Pilozzi E., Biffoni M., Todaro M., Peschle C., De Maria R. Identification and expansion of human colon-cancer-initiating cells. Nature 2007, 445:111-115.
4. Li C., Heidt D.G., Dalerba P., Burant C.F., Zhang L., Adsay V., Wicha M., Clarke M.F., Simeone D.M. Identification of pancreatic cancer stem cells. Cancer Res. 2007, 67:1030-1037.
5. Singh S.K., Clarke I.D., Terasaki M., Bonn V.E., Hawkins C., Squire J., Dirks P.B. Identification of a cancer stem cell in human brain tumors. Cancer Res. 2003, 63:5821-5828.
6. Patrawala L., Calhoun T., Schneider-Broussard R., Li H., Bhatia B., Tang S., Reilly J.G., Chandra D., Zhou J., Claypool K., Coghlan L., Tang D.G. Highly purified CD44+ prostate cancer cells from xenograft human tumors are enriched in tumorigenic and metastatic progenitor cells. Oncogene 2006, 25:1696-1708.
7. Hurt E.M., Kawasaki B.T., Klarmann G.J., Thomas S.B., Farrar W.L. CD44+ CD24(-) prostate cells are early cancer progenitor/stem cells that provide a model for patients with poor prognosis. Br. J. Cancer 2008, 98:756-765.
8. Lobo N.A., Shimono Y., Qian D., Clarke M.F. The biology of cancer stem cells. Annu. Rev. Cell Dev. Biol. 2007, 23:675-699.
9. Ji Q., Karnak D., Hao P., Wang R., Xu L. No small matter: microRNAs - key regulators of cancer stem cells. Int. J. Clin. Exp. Med. 2010, 3:84-87.
10. Garzon R., Fabbri M., Cimmino A., Calin G.A., Croce C.M. MicroRNA expression and function in cancer. Trends Mol. Med. 2006, 12:580-587.
11. Garzon R., Calin G.A., Croce C.M. MicroRNAs in cancer. Annu. Rev. Med. 2009, 60:167-179.
12. Hime G.R., Somers W.G. Micro-RNA mediated regulation of proliferation, self-renewal and differentiation of mammalian stem cells. Cell Adh. Migr. 2009, 3:425-432.
13. Ferland-McCollough D., Ozanne S.E., Siddle K., Willis A.E., Bushell M. The involvement of microRNAs in Type 2 diabetes. Biochem. Soc. Trans. 2011, 38:1565-1570.
14. Hatfield S., Ruohola-Baker H. microRNA and stem cell function. Cell Tissue Res. 2008, 331:57-66.
15. Duhagon M.A., Hurt E.M., Sotelo-Silveira J.R., Zhang X., Farrar W.L. Genomic profiling of tumor initiating prostatospheres. BMC Genomics 2010, 11:324.
16. Bomken S., Fiser K., Heidenreich O., Vormoor J. Understanding the cancer stem cell. Br J Cancer 2010, 103:439-445.
17. Bisson I., Prowse D.M. WNT signaling regulates self-renewal and differentiation of prostate cancer cells with stem cell characteristics. Cell Res. 2009, 19:683-697.
18. Katoh M., Katoh M. WNT signaling pathway and stem cell signaling network. Clin. Cancer Res. 2007, 13:4042-4045.
19. Hurt E.M., Chan K., Serrat M.A., Thomas S.B., Veenstra T.D., Farrar W.L. Identification of vitronectin as an extrinsic inducer of cancer stem cell differentiation and tumor formation. Stem Cells 2010, 28:390-398.
20. Mandalaywala N.V., Chang S., Snyder R.G., Levendusky M.C., Voigt J.M., Dearborn R.E. The tumor suppressor, vitamin D3 up-regulated protein 1 (VDUP1), functions downstream of REPO during Drosophila gliogenesis. Dev. Biol. 2008, 315:489-504.
21. Levendusky M.C., Basle J., Chang S., Mandalaywala N.V., Voigt J.M., Dearborn R.E. Expression and regulation of vitamin D3 upregulated protein 1 (VDUP1) is conserved in mammalian and insect brain. J. Comp. Neurol. 2009, 517:581-600.
22. Hwang H.W., Wentzel E.A., Mendell J.T. Cell-cell contact globally activates microRNA biogenesis. Proc. Natl. Acad. Sci. U. S. A. 2009, 106:7016-7021.
23. Volinia S., Calin G.A., Liu C.G., Ambs S., Cimmino A., Petrocca F., Visone R., Iorio M., Roldo C., Ferracin M., Prueitt R.L., Yanaihara N., Lanza G., Scarpa A., Vecchione A., Negrini M., Harris C.C., Croce C.M. A microRNA expression signature of human solid tumors defines cancer gene targets. Proc. Natl. Acad. Sci. U. S. A. 2006, 103:2257-2261.
24. Hummel R., Hussey D.J., Haier J. MicroRNAs: predictors and modifiers of chemo- and radiotherapy in different tumour types. Eur. J. Cancer 2010, 46:298-311.
25. Chen Y., Gorski D.H. Regulation of angiogenesis through a microRNA (miR-130a) that down-regulates antiangiogenic homeobox genes GAX and HOXA5. Blood 2008, 111:1217-1226.
26. Gao W., Shen H., Liu L., Xu J., Shu Y. MiR-21 overexpression in human primary squamous cell lung carcinoma is associated with poor patient prognosis. J. Cancer Res. Clin. Oncol. 2011, 137(4):557-566. (Apr).
27. Witten D., Tibshirani R., Gu S.G., Fire A., Lui W.O. Ultra-high throughput sequencing-based small RNA discovery and discrete statistical biomarker analysis in a collection of cervical tumours and matched controls. BMC Biol. 2010, 8:58.
28. Lui W.O., Pourmand N., Patterson B.K., Fire A. Patterns of known and novel small RNAs in human cervical cancer. Cancer Res. 2007, 67:6031-6043.
29. Tong A.W., Fulgham P., Jay C., Chen P., Khalil I., Liu S., Senzer N., Eklund A.C., Han J., Nemunaitis J. MicroRNA profile analysis of human prostate cancers. Cancer Gene Ther. 2009, 16:206-216.
30. Mathe E.A., Nguyen G.H., Bowman E.D., Zhao Y., Budhu A., Schetter A.J., Braun R., Reimers M., Kumamoto K., Hughes D., Altorki N.K., Casson A.G., Liu C.G., Wang X.W., Yanaihara N., Hagiwara N., Dannenberg A.J., Miyashita M., Croce C.M., Harris C.C. MicroRNA expression in squamous cell carcinoma and adenocarcinoma of the esophagus: associations with survival. Clin. Cancer Res. 2009, 15:6192-6200.
31. Mees S.T., Mardin W.A., Wendel C., Baeumer N., Willscher E., Senninger N., Schleicher C., Colombo-Benkmann M., Haier J. EP300 - a miRNA-regulated metastasis suppressor gene in ductal adenocarcinomas of the pancreas. Int. J. Cancer 2010, 126:114-124.
32. Wong T.S., Liu X.B., Wong B.Y., Ng R.W., Yuen A.P., Wei W.I. Mature miR-184 as potential oncogenic microRNA of squamous cell carcinoma of tongue. Clin. Cancer Res. 2008, 14:2588-2592.
33. van Jaarsveld M.T., Helleman J., Berns E.M., Wiemer E.A. MicroRNAs in ovarian cancer biology and therapy resistance. Int. J. Biochem. Cell Biol. 2010, 42:1282-1290.
34. Hu Y., Correa A.M., Hoque A., Guan B., Ye F., Huang J., Swisher S.G., Wu T.T., Ajani J.A., Xu X.C. Prognostic significance of differentially expressed miRNAs in esophageal cancer. Int. J. Cancer 2011, 128(1):132-143. (Jan 1).
35. Baffa R., Fassan M., Volinia S., O'Hara B., Liu C.G., Palazzo J.P., Gardiman M., Rugge M., Gomella L.G., Croce C.M., Rosenberg A. MicroRNA expression profiling of human metastatic cancers identifies cancer gene targets. J. Pathol. 2009, 219:214-221.
36. Yang Y., Li X., Yang Q., Wang X., Zhou Y., Jiang T., Ma Q., Wang Y.J. The role of microRNA in human lung squamous cell carcinoma. Cancer Genet. Cytogenet. 2010, 200:127-133.
37. Yao J., Liang L., Huang S., Ding J., Tan N., Zhao Y., Yan M., Ge C., Zhang Z., Chen T., Wan D., Yao M., Li J., Gu J., He X. MicroRNA-30d promotes tumor invasion and metastasis by targeting Galphai2 in hepatocellular carcinoma. Hepatology 2010, 51:846-856.
38. Lu Y., Ryan S.L., Elliott D.J., Bignell G.R., Futreal P.A., Ellison D.W., Bailey S., Clifford S.C. Amplification and overexpression of Hsa-miR-30b, Hsa-miR-30d and KHDRBS3 at 8q24.22-q24.23 in medulloblastoma. PLoS One 2009, 4:e6159.
39. Moreno C.S. The sex-determining region Y-box 4 and homeobox C6 transcriptional networks in prostate cancer progression: crosstalk with the Wnt, Notch, and PI3K pathways. Am. J. Pathol. 2010, 176:518-527.
40. Martinez-Morales P.L., Quiroga A.C., Barbas J.A., Morales A.V. SOX5 controls cell cycle progression in neural progenitors by interfering with the WNT-beta-catenin pathway. EMBO Rep 2010, 11:466-472.
41. Kan L., Israsena N., Zhang Z., Hu M., Zhao L.R., Jalali A., Sahni V., Kessler J.A. Sox1 acts through multiple independent pathways to promote neurogenesis. Dev. Biol. 2004, 269:580-594.
42. Aaboe M., Birkenkamp-Demtroder K., Wiuf C., Sorensen F.B., Thykjaer T., Sauter G., Jensen K.M., Dyrskjot L., Orntoft T. SOX4 expression in bladder carcinoma: clinical aspects and in vitro functional characterization. Cancer Res. 2006, 66:3434-3442.
43. Geijsen N., Uings I.J., Pals C., Armstrong J., McKinnon M., Raaijmakers J.A.M., Lammers J.-W.J., Koenderman L., Coffer P.J. Cytokine-specific transcriptional regulation through an IL-5Ralpha interacting protein. Science 2001, 293:1136-1138.
44. Estrach S., Legg J., Watt F.M. Syntenin mediates delta1-induced cohesiveness of epidermal stem cells in culture. J. Cell Sci. 2007, 120:2944-2952.
45. Kramps T., Peter O., Brunner E., Nellen D., Froesch B., Chatterjee S., Murone M., Züllig S., Basler K. Wnt/wingless signaling requires BCL9/legless-mediated recruitment of Pygopus to the nuclear [beta]-catenin-TCF complex. Cell 2002, 109:47-60.
46. Mani M., Carrasco D.E., Zhang Y., Takada K., Gatt M.E., Dutta-Simmons J., Ikeda H., Diaz-Griffero F., Pena-Cruz V., Bertagnolli M., Myeroff L.L., Markowitz S.D., Anderson K.C., Carrasco D.R. BCL9 promotes tumor progression by conferring enhanced proliferative, metastatic, and angiogenic properties to cancer cells. Cancer Res. 2009, 69:7577-7586.
47. Deka J., Wiedemann N., Anderle P., Murphy-Seiler F., Bultinck J., Eyckerman S., Stehle J.C., Andre S., Vilain N., Zilian O., Robine S., Delorenzi M., Basler K., Aguet M. Bcl9/Bcl9l are critical for Wnt-mediated regulation of stem cell traits in colon epithelium and adenocarcinomas. Cancer Res. 2010, 70:6619-6628.
48. Moore N., Lyle S. Quiescent, slow-cycling stem cell populations in cancer: a review of the evidence and discussion of significance. J. Oncol. 2010, 2011.
49. Chen K.S., DeLuca H.F. Isolation and characterization of a novel cDNA from HL-60 cells treated with 1,25-dihydroxyvitamin D-3. Biochim. Biophys. Acta 1994, 1219:26-32.
50. Goldberg S.F., Miele M.E., Hatta N., Takata M., Paquette-Straub C., Freedman L.P., Welch D.R. Melanoma metastasis suppression by chromosome 6: evidence for a pathway regulated by CRSP3 and TXNIP. Cancer Res. 2003, 63:432-440.
51. Dutta K.K., Nishinaka Y., Masutani H., Akatsuka S., Aung T.T., Shirase T., Lee W.H., Yamada Y., Hiai H., Yodoi J., Toyokuni S. Two distinct mechanisms for loss of thioredoxin-binding protein-2 in oxidative stress-induced renal carcinogenesis. Lab. Invest. 2005, 85:798-807.
52. Pang S.T., Hsieh W.C., Chuang C.K., Chao C.H., Weng W.H., Juang H.H. Thioredoxin-interacting protein: an oxidative stress-related gene is upregulated by glucose in human prostate carcinoma cells. J. Mol. Endocrinol. 2009, 42:205-214.
53. Jeong M., Piao Z.H., Kim M.S., Lee S.H., Yun S., Sun H.N., Yoon S.R., Chung J.W., Kim T.D., Jeon J.H., Lee J., Kim H.N., Choi J.Y., Choi I. Thioredoxin-interacting protein regulates hematopoietic stem cell quiescence and mobilization under stress conditions. J. Immunol. 2009, 183:2495-2505.